Literature DB >> 14410972

Genetic markers and serological identity of wild and attenuated strains of type-1 poliovirus, with special emphasis on strains isolated from patients during an epidemic in the Belgian Congo.

H KOPROWSKI, T W NORTON, E WECKER, S GARD.   

Abstract

An epidemic of paralytic poliomyelitis occurred in Léopoldville at a time when both virulent and attenuated type 1 polioviruses were present in the population. The attenuated virus was of the CHAT strain, then being given extensive field trials as a vaccine in the Belgian Congo. It was thought that intratypic identification of "wild" and vaccine strains might give information on the hypothetical possibility of a reversion to virulence of attenuated strains. Viruses were isolated from the stools of patients with paralytic poliomyelitis, both those who had not been vaccinated and those who had previously been fed the CHAT attenuated vaccine. Other viruses studied were CHAT virus itself and strains obtained from first, second and third human passages; Mahoney, a virulent strain; W 1063, a "naturally attenuated" strain; and Sickle, a strain, which, in mixture with Mahoney strain, constituted the initial inoculum from which CHAT had been derived. Serologically, the strains were tested for growth in the presence of an agar overlay containing CHAT immune serum. Genetically, the strains were characterized by a study of genetic markers relating to growth under agar of low bicarbonate content (d character), comparative growth in a fresh versus the MS established line of monkey kidney tissue culture, and temperature susceptibility at 37 degrees C and 40 degrees C. The Léopoldville strains and Mahoney were able to produce plaques when grown under overlay containing CHAT immune serum, and they had d+, MS+ and "hot" characters. CHAT and its derivatives were d, MS and "cold"-in other words, exactly opposite in all respects studied. Sickle and W 1063 were intermediate.Evidence is given that CHAT is genetically stable through several human passages, that the poliomyelitis cases in vaccinees were not caused by vaccination, and that the hypothesis of a return to virulence of attenuated strains has not been substantiated.

Entities:  

Keywords:  POLIOMYELITIS VIRUSES

Mesh:

Substances:

Year:  1960        PMID: 14410972      PMCID: PMC2555337     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14

2.  Clinical trials in infants of orally administered attenuated poliomyelitis viruses.

Authors:  S A PLOTKIN; H KOPROWSKI; J STOKES
Journal:  Pediatrics       Date:  1959-06       Impact factor: 7.124

3.  Factors influencing the evolution of viral diseases at the cellular level and in the organism.

Authors:  A LWOFF
Journal:  Bacteriol Rev       Date:  1959-09

4.  Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households.

Authors:  H M GELFAND; D R LEBLANC; J P FOX; D P CONWELL
Journal:  Am J Hyg       Date:  1957-05

5.  Immuno-inactivation of poliovirus.

Authors:  S GARD
Journal:  Arch Gesamte Virusforsch       Date:  1957

6.  Study of the mutability of d lines of polioviruses.

Authors:  R DULBECCO; M VOGT
Journal:  Virology       Date:  1958-04       Impact factor: 3.616

7.  [Inhibition of the development of poliomyelitis virus at 39 degrees & the problem of the role of hyperthermia in the evolution of viral infections].

Authors:  A LWOFF; M LWOFF
Journal:  C R Hebd Seances Acad Sci       Date:  1958-01-06

8.  Adaptation of type I strain of poliomyelitis virus to mice and cotton rats.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON; K PFEISTER
Journal:  Proc Soc Exp Biol Med       Date:  1954-06
  8 in total
  3 in total

1.  Serodifferentiation of poliovirus strains for studies of oral vaccine.

Authors:  H M GELFAND; J H NAKANO; J T COLE
Journal:  Public Health Rep       Date:  1962-11       Impact factor: 2.792

2.  Recent results of mass immunization against poliomyelitis with Koprowski strains of attenuated live poliovirus.

Authors:  S A PLOTKIN
Journal:  Am J Public Health Nations Health       Date:  1962-06

3.  Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo. 3. Safety and efficacy during the first 21 months of study.

Authors:  S A PLOTKIN; A LEBRUN; G COURTOIS; H KOPROWSKI
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.